Targeting corroles for tumor toxicity and mri
AssigneeCedars-Sinai Medical Center
InventorLali K. MEDINA-KAUWE
Life of this patent
Estimating the term…
Loading patent…
AssigneeCedars-Sinai Medical Center
InventorLali K. MEDINA-KAUWE
Estimating the term…
Disclosed herein are compositions comprising a targeted corrole nanoparticle; and an acceptable excipient. Also disclosed are compositions comprising a targeted corrole nanoparticle; and an acceptable carrier. Further, disclosed herein are methods of imaging a condition in a subject, comprising providing a composition comprising a targeted corrole nanoparticle; administering an effective amount of the targeted corrole nanoparticle to the subject; and imaging the condition in the subject. In addition, disclosed herein are methods of treating cancer in a subject, comprising providing a composition comprising a targeted corrole nanoparticle; and administering a therapeutically effective dosage of the targeted corrole nanoparticle to the subject.
A method of treating cancer in a subject, comprising:
A method of imaging a condition in a subject, comprising:
A composition comprising a targeted corrole nanoparticle;
The method of claim erein the targeted corrole nanoparticle is HerMn, HerFe, or HerGa.
Dependencies are inferred from the claim text.